Astrocyte-derived tissue Transglutaminase interacts with fibronectin: A role in astrocyte adhesion and migration?

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  van Strien, Miriam E ^a,b   Brevé, John J P ^a   Fratantoni, Silvina ^a,c   Schreurs, Marco W J ^a   Bol, John G J M ^a   Jongenelen, Cornelis A M ^a   Drukarch, Benjamin ^a   van Dam, Anne Marie ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c Galapagos BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTERLEUKIN 1BETA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SCLEROPROTEIN; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA; TISSUE TRANSGLUTAMINASE 2, HUMAN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ADHESION; CELL MIGRATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FOCAL ADHESION; GLIA CELL; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; CELL CULTURE; CELL MEMBRANE; CELL MOTION; CELL PROLIFERATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

RATTUS;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBRONECTINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSGLUTAMINASES;

EID: 80052831708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025037     Document Type: Article

References (55)

1. Nimmerjahn A, (2009) Astrocytes going live: advances and challenges. J Physiol 587: 1639-1647.
2. Ridet JL, Malhotra SK, Privat A, Gage FH, (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570-577.
3. Sofroniew MV, (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647.
4. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, et al. (2009) Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29: 11511-11522.
5. Fawcett JW, Asher RA, (1999) The glial scar and central nervous system repair. Brain Res Bull 49: 377-391.
6. Berry M, Maxwell WL, Logan A, Mathewson A, McConnell P, et al. (1983) Deposition of scar tissue in the central nervous system. Acta Neurochir Suppl (Wien) 32: 31-53.
7. Reier PJ, Houle JD, (1988) The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol 47: 87-138.
8. Becher B, Prat A, Antel JP, (2000) Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29: 293-304.
9. John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A, et al. (2004) Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci 24: 2837-2845.
10. Czopka T, Von Holst A, Schmidt G, Ffrench-Constant C, Faissner A, (2009) Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia 57: 1790-1801.
11. Siskova Z, Baron W, de Vries H, Hoekstra D, (2006) Fibronectin impedes "myelin" sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Mol Cell Neurosci 33: 150-159.
12. Siskova Z, Yong VW, Nomden A, van Strien M, Hoekstra D, et al. (2009) Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity. Mol Cell Neurosci 42: 234-242.
13. Kim SY, Jeong EJ, Steinert PM, (2002) IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells. J Interferon Cytokine Res 22: 677-682.
14. Quan G, Choi JY, Lee DS, Lee SC, (2005) TGF-beta1 up-regulates transglutaminase two and fibronectin in dermal fibroblasts: a possible mechanism for the stabilization of tissue inflammation. Arch Dermatol Res 297: 84-90.
15. Fesus L, Piacentini M, (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27: 534-539.
16. Akimov SS, Belkin AM, (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98: 1567-1576.
17. Hodrea J, Demeny MA, Majai G, Sarang Z, Korponay-Szabo IR, et al. (2010) Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages. Immunol Lett 130: 74-81.
18. Gaudry CA, Verderio E, Jones RA, Smith C, Griffin M, (1999) Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res 252: 104-113.
19. Telci D, Collighan RJ, Basaga H, Griffin M, (2009) Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem 284: 29547-29558.
20. Fisher M, Jones RA, Huang L, Haylor JL, El Nahas M, et al. (2009) Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring. Matrix Biol 28: 20-31.
21. Verderio EA, Johnson T, Griffin M, (2004) Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 26: 387-404.
22. Small JV, Rottner K, Kaverina I, (1999) Functional design in the actin cytoskeleton. Curr Opin Cell Biol 11: 54-60.
23. Smilenov LB, Mikhailov A, Pelham RJ, Marcantonio EE, Gundersen GG, (1999) Focal adhesion motility revealed in stationary fibroblasts. Science 286: 1172-1174.
24. McCarthy KD, de Vellis J, (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
25. Choi K, Siegel M, Piper JL, Yuan L, Cho E, et al. (2005) Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol 12: 469-475.
26. Breve JJ, Drukarch B, van Strien M, van Dam AM, (2008) Validated sandwich ELISA for the quantification of tissue transglutaminase in tissue homogenates and cell lysates of multiple species. J Immunol Methods 332: 142-150.
27. Sakly W, Thomas V, Quash G, El Alaoui S, (2006) A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity. Clin Exp Immunol 146: 550-558.
28. Jones RA, Nicholas B, Mian S, Davies PJ, Griffin M, (1997) Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 110 (Pt 19): 2461-2472.
29. van Strien ME, Drukarch B, Bol JG, van der Valk P, van Horssen J, et al. (2011) Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration? Brain Pathol 21: 44-54.
30. Sarafian TA, Bredesen DE, (1994) Is apoptosis mediated by reactive oxygen species? Free Radic Res 21: 1-8.
31. Wehrle-Haller B, Imhof B, (2002) The inner lives of focal adhesions. Trends Cell Biol 12: 382-389.
32. Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, et al. (2003) Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol 162: 2041-2057.
33. Monsonego A, Shani Y, Friedmann I, Paas Y, Eizenberg O, et al. (1997) Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J Biol Chem 272: 3724-3732.
34. Iyoda M, Shibata T, Kawaguchi M, Hizawa N, Yamaoka T, et al. (2010) IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. Am J Physiol Renal Physiol 298: F779-F787.
35. Kelley MJ, Rose AY, Song K, Chen Y, Bradley JM, et al. (2007) Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork. Invest Ophthalmol Vis Sci 48: 2634-2643.
36. Yeruva S, Ramadori G, Raddatz D, (2008) NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis 23: 305-317.
37. Paludan SR, (2000) Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J Leukoc Biol 67: 18-25.
38. Priglinger SG, Alge CS, Neubauer AS, Kristin N, Hirneiss C, et al. (2004) TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain. Invest Ophthalmol Vis Sci 45: 955-963.
39. Heath DJ, Downes S, Verderio E, Griffin M, (2001) Characterization of tissue transglutaminase in human osteoblast-like cells. J Bone Miner Res 16: 1477-1485.
40. Milner R, Crocker SJ, Hung S, Wang X, Frausto RF, et al. (2007) Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5. J Immunol 178: 8158-8167.
41. Sobel RA, Mitchell ME, (1989) Fibronectin in multiple sclerosis lesions. Am J Pathol 135: 161-168.
42. van Horssen J, Dijkstra CD, de Vries HE, (2007) The extracellular matrix in multiple sclerosis pathology. J Neurochem 103: 1293-1301.
43. Turner PM, Lorand L, (1989) Complexation of fibronectin with tissue transglutaminase. Biochemistry 28: 628-635.
44. Akimov SS, Krylov D, Fleischman LF, Belkin AM, (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148: 825-838.
45. Radek JT, Jeong JM, Murthy SN, Ingham KC, Lorand L, (1993) Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc Natl Acad Sci U S A 90: 3152-3156.
46. Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K, (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26: 2459-2470.
47. Wang Z, Telci D, Griffin M, (2011) Importance of syndecan-4 and syndecan-2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res 317: 367-381.
48. Lee EJ, Kim WJ, Moon SK, (2010) Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells. Phytother Res 24: 1755-1761.
49. Zhang A, Wang Y, Ye Z, Xie H, Zhou L, et al. (2010) Mechanism of TNF-alpha-induced migration and hepatocyte growth factor production in human mesenchymal stem cells. J Cell Biochem 111: 469-475.
50. Striedinger K, Scemes E, (2008) Interleukin-1beta affects calcium signaling and in vitro cell migration of astrocyte progenitors. J Neuroimmunol 196: 116-123.
51. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J, (1997) Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17: 490-497.
52. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, et al. (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res 66: 8788-8795.
53. Park KS, Kim DS, Ko C, Lee SJ, Oh SH, et al. (2011) TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2. Front Biosci (Elite Ed) 3: 341-354.
54. Verma A, Guha S, Wang H, Fok JY, Koul D, et al. (2008) Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res 14: 1997-2005.
55. Song H, Chang W, Lim S, Seo HS, Shim CY, et al. (2007) Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells 25: 1431-1438.